Cargando…

A Novel Inhibitor of STAT5 Signaling Overcomes Chemotherapy Resistance in Myeloid Leukemia Cells

Signal transducers and activators of transcription 5A and 5B (STAT5A and STAT5B) are crucial downstream effectors of tyrosine kinase oncogenes (TKO) such as BCR-ABL in chronic myeloid leukemia (CML) and FLT3-ITD in acute myeloid leukemia (AML). Both proteins have been shown to promote the resistance...

Descripción completa

Detalles Bibliográficos
Autores principales:	Brachet-Botineau, Marie, Deynoux, Margaux, Vallet, Nicolas, Polomski, Marion, Juen, Ludovic, Hérault, Olivier, Mazurier, Frédéric, Viaud-Massuard, Marie-Claude, Prié, Gildas, Gouilleux, Fabrice
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6966442/ https://www.ncbi.nlm.nih.gov/pubmed/31861239 http://dx.doi.org/10.3390/cancers11122043

Ejemplares similares

Pharmacological Inhibition of Oncogenic STAT3 and STAT5 Signaling in Hematopoietic Cancers
por: Brachet-Botineau, Marie, et al.
Publicado: (2020)

Acriflavine targets oncogenic STAT5 signaling in myeloid leukemia cells
por: Hallal, Rawan, et al.
Publicado: (2020)

VAS3947 Induces UPR-Mediated Apoptosis through Cysteine Thiol Alkylation in AML Cell Lines
por: El Dor, Maya, et al.
Publicado: (2020)

Oncogenic STAT5 signaling promotes oxidative stress in chronic myeloid leukemia cells by repressing antioxidant defenses
por: Bourgeais, Jerome, et al.
Publicado: (2016)

Hypoxia and Hypoxia-Inducible Factors in Leukemias
por: Deynoux, Margaux, et al.
Publicado: (2016)

New Quinoxaline Derivatives as Dual Pim-1/2 Kinase Inhibitors: Design, Synthesis and Biological Evaluation
por: Oyallon, Bruno, et al.
Publicado: (2021)

Characterization of NADPH Oxidase Expression and Activity in Acute Myeloid Leukemia Cell Lines: A Correlation with the Differentiation Status
por: Dakik, Hassan, et al.
Publicado: (2021)

Diphenyleneiodonium Triggers Cell Death of Acute Myeloid Leukemia Cells by Blocking the Mitochondrial Respiratory Chain, and Synergizes with Cytarabine
por: Dakik, Hassan, et al.
Publicado: (2022)

Impact of Maleimide Disubstitution on Chemical and Biological Characteristics of HER2 Antibody–Drug Conjugates
por: Feuillâtre, Ofelia, et al.
Publicado: (2020)

In Vitro Characterization and Stability Profiles of Antibody–Fluorophore Conjugates Derived from Interchain Cysteine Cross-Linking or Lysine Bioconjugation
por: Martin, Camille, et al.
Publicado: (2019)

α-Lithiation and Electrophilic Substitution of 1,4,4-Trimethyl-3,4-dihydroquinolin-2-one
por: Sébastien, Bouclé, et al.
Publicado: (2010)

Oxidative metabolism in cancer: A STAT affair?
por: Bourgeais, Jérome, et al.
Publicado: (2013)

STAT5A/5B-specific expansion and transformation of hematopoietic stem cells
por: Ghanem, S, et al.
Publicado: (2017)

A comparative study of the capacity of mesenchymal stromal cell lines to form spheroids
por: Deynoux, Margaux, et al.
Publicado: (2020)

Dibenzofuran Derivatives Inspired from Cercosporamide as Dual Inhibitors of Pim and CLK1 Kinases
por: Dao, Viet Hung, et al.
Publicado: (2021)

Antibody-drug conjugates: Design and development for therapy and imaging in and beyond cancer, LabEx MAbImprove industrial workshop, July 27–28, 2017, Tours, France
por: Martin, Camille, et al.
Publicado: (2018)

Disruption of gap junctions attenuates acute myeloid leukemia chemoresistance induced by bone marrow mesenchymal stromal cells
por: Kouzi, Farah, et al.
Publicado: (2019)

Correction: Disruption of gap junctions attenuates acute myeloid leukemia chemoresistance induced by bone marrow mesenchymal stromal cells
por: Kouzi, Farah, et al.
Publicado: (2019)

Combined targeting of STAT3 and STAT5: a novel approach to overcome drug resistance in chronic myeloid leukemia
por: Gleixner, Karoline V., et al.
Publicado: (2017)

Occupational pesticide exposure increases risk of acute myeloid leukemia: a meta-analysis of case–control studies including 3,955 cases and 9,948 controls
por: Foucault, Amelie, et al.
Publicado: (2021)

Cyclin D1 unbalances the redox status controlling cell adhesion, migration, and drug resistance in myeloma cells
por: Bustany, Sophie, et al.
Publicado: (2016)

Anticalin N- or C-Terminal on a Monoclonal Antibody Affects Both Production and In Vitro Functionality
por: Aubrey, Nicolas, et al.
Publicado: (2022)

The neonatal Fc receptor in cancer FcRn in cancer
por: Cadena Castaneda, Diana, et al.
Publicado: (2020)

Antibody–Drug Conjugates as an Emerging Therapy in Oncodermatology
por: Esnault, Clara, et al.
Publicado: (2022)

“Ways in which the neonatal Fc-receptor is involved in autoimmunity”
por: Lamamy, Juliette, et al.
Publicado: (2021)

Effective targeting of STAT5-mediated survival in myeloproliferative neoplasms using ABT-737 combined with rapamycin
por: Li, Geqiang, et al.
Publicado: (2010)

Human hematopoietic stem/progenitor cells display reactive oxygen species-dependent long-term hematopoietic defects after exposure to low doses of ionizing radiations
por: Henry, Elia, et al.
Publicado: (2020)

Investigating the potential therapeutic role of targeting STAT3 for overcoming drug resistance by regulating energy metabolism in chronic myeloid leukemia cells
por: Tezcanli Kaymaz, Burcin, et al.
Publicado: (2022)

Overcoming Chemoresistance of Pediatric Ependymoma by Inhibition of STAT3 Signaling
por: Phi, Ji Hoon, et al.
Publicado: (2015)

Implementation Study of Patient-Ready Syringes Containing 25 mg/mL Methotrexate Solution for Use in Treating Ectopic Pregnancy
por: Respaud, R., et al.
Publicado: (2014)

Stat3 targeted therapies overcome the acquired resistance to vemurafenib in melanomas
por: Liu, Fang, et al.
Publicado: (2013)

STAT signaling in the pathogenesis and treatment of myeloid malignancies
por: Bar-Natan, Michal, et al.
Publicado: (2012)

Overcoming Resistance to Kinase Inhibitors: The Paradigm of Chronic Myeloid Leukemia
por: De Santis, Sara, et al.
Publicado: (2022)

O-GlcNAcylation of STAT5 controls tyrosine phosphorylation and oncogenic transcription in STAT5-dependent malignancies
por: Freund, P, et al.
Publicado: (2017)

Selective activation of STAT3 and STAT5 dictates the fate of myeloid progenitor cells
por: Zhang, Meichao, et al.
Publicado: (2023)

Overcoming chemo/radio-resistance of pancreatic cancer by inhibiting STAT3 signaling
por: Wu, Xiaoqing, et al.
Publicado: (2016)

Targeting IFN/STAT1 Pathway as a Promising Strategy to Overcome Radioresistance
por: Liu, Shuya, et al.
Publicado: (2020)

Therapeutic antibodies – natural and pathological barriers and strategies to overcome them
por: Al Ojaimi, Yara, et al.
Publicado: (2022)

Pharmacologic inhibition of STAT5 in acute myeloid leukemia
por: Wingelhofer, Bettina, et al.
Publicado: (2018)

The Ups and Downs of STAT Inhibition in Acute Myeloid Leukemia
por: Moser, Bernhard, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_5r881a53734mbmkc82h4f52ik1